
    
      The outcome measure of the study is a combined endpoint of:

        -  Proportion of patients with HF hospitalization or emergency unit admission with
           intravenous diuretics, Atrial Tachycardia/Atrial Fibrillation (AT/AF) episodes or
           cardiovascular/cerebrovascular episodes requiring hospitalization at 12 months

        -  Proportion of patients with inappropriate Implantable Cardioverter-Defibrillator (ICD)
           therapies delivered at 12 months comparing optimized remote patient management to
           optimized standard patient management
    
  